AstraZeneca today announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio. In the first instance, AstraZeneca intends to apply Illumina’s cutting-edge technology to a novel companion diagnostic test in pivotal studies for one […]
Durham, NC and Manassas, VA– ATCC, the premier global biological materials resource and standards organization, and bioMérieux, a world leader in the field of in vitro diagnostics, announced today their collaboration to expand and solidify the bioMérieux VITEK® MS microbial identification database for the industrial market. Recently, ATCC acquired the bioMérieux VITEK® MS system to […]
The Ion PGM is a fast and cost-effective platform for next generation sequencing applications. The release of the Ion TrueMate™ Library Kit will expand the platform’s capabilities by allowing long mate pair libraries up to 8 kb to be run on the PGM. Mate pair libraries are critical for de novo genome assembly, chromosomal rearrangement […]
PALO ALTO, Calif. — Cellular Research announced today the start of an early access program for its Precise™ assays and is currently making the product available to 10 sites. The Precise assays provide ultra-sensitive RNASeq assay technology designed to examine large numbers of standard or low input mRNA samples in high throughput. Based on Cellular […]
Chicago, Illinois & Los Altos, California — Igenbio, Inc., a Chicago based genome analysis company, announced today that they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company. The collaboration is to create comprehensive synthetic biology solutions using Igenbio flagship product, ERGO™, the next generation Genome Analysis […]
Ipswich, MA, USA — New England Biolabs, Inc. (NEB®) today announced that NEB has exclusively in-licensed rights from Genomic Health, Inc. to its technology for the depletion of abundant RNAs, which is instrumental to performing sensitive RNA-seq experiments at a lower cost. Ribosomal RNAs (rRNAs) are extremely abundant, constituting approximately 90% of total RNA. For […]
Allentown PA — Micro Photonics, Inc., the leading source of advanced X-ray computed tomography instruments, announced today the release of the SkyScan-2211 Multi-Scale Nano-CT. The SkyScan 2211 represents a new generation of Nano-CT from Bruker MicroCT N.V., with nondestructive 3D imaging capabilities of internal structures from the submicron range to the very large. This advanced […]
Pleasanton, CA, USA — Roche (SIX: RO, ROG; OTCQX: RHHBY) and the Garvan Institute of Medical Research today announce a collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing. Genomics is a rapidly evolving field with a focus on realizing the potential use of sequencing information in patient diagnosis and treatment. More […]
PALO ALTO, Calif. — Cellular Research announced today the start of an early access program for its Precise™ assays and is currently making the product available to 10 sites. The Precise assays provide ultra-sensitive RNASeq assay technology designed to examine large numbers of standard or low input mRNA samples in high throughput. Based on Cellular […]
CHICAGO, IL –- GTCR, a leading private equity firm, today announced that it has completed the previously announced acquisition of Cole-Parmer Instrument Company (“Cole-Parmer” or the “Business”) from Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”). Cole-Parmer, headquartered in Vernon Hills, Illinois, is a leading global manufacturer and distributor of specialty laboratory equipment, instruments and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
